The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical Centers
Abstract
PURPOSE: To determine the incidence and associated risk factors of nephrogenic systemic fibrosis (NSF) in patients who undergo gadolinium-based contrast agent (GBCA)-enhanced magnetic resonance (MR) imaging. MATERIALS AND METHODS: Institutional review board approval was obtained for retrospective review of the medical records from two hospitals to identify all cases of biopsy-confirmed NSF and all patients administered a GBCA from January 1, 1997, to June 30, 2007. Informed patient consent was not required. The incidence of NSF was calculated for patients who received a standard dose of GBCA, patients who received a high dose, and subgroups of patients with renal impairment. RESULTS: Fifteen patients developed NSF after gadolinium-enhanced MR imaging. All of them had an estimated glomerular filtration rate (eGFR) lower than 30 mL/min, and 11 had acute renal failure or acute deterioration of chronic renal failure. The incidence of NSF after gadolinium-enhanced MR imaging without screening for renal function was zero of 74,124 patients with the standard dose of GBCA and 15 (0.17%) of 8997 patients with the high dose (P < .001). The NSF incidence associated with a high dose of GBCA increased to 0.4% in patients in a chronic hemodialysis program and to 8.8% in those who had an eGFR lower than 15 mL/min but were not undergoing hemodialysis (P < .001). The NSF incidence in the patients with acute renal failure who received a high dose when their creatinine level was increasing was 19% (11 of 58 patients) when hemodialysis was delayed for longer than 2 days. More patients with NSF had proinflammatory events, and compared with patients without NSF, these patients had lower pH, younger age, lower eGFR, elevated serum phosphorus levels, and a longer delay between GBCA injection and hemodialysis. CONCLUSION: For patients with an eGFR lower than 15 mL/min, hemodialysis helped to prevent NSF. For patients with an eGFR lower than 30 mL/min who received a high dose of GBCA, acute renal failure, delayed hemodialysis after contrast agent injection, proinflammatory events, and hyperphosphatemia were associated with increased risk of NSF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grobner, T. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk062 · Cited by 1,859
Marckmann, P., Skov, L., Rossen, K., Dupont, A., Damholt, M. B., Heaf, J. G., & Thomsen, H. S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060601 · Cited by 1,400
Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation
Sadowski, E. A., Bennett, L. K., Chan, M. R., Wentland, A. L., Garrett, A. L., Garrett, R. W., & Djamali, A. (2007) · Radiology · doi:10.1148/radiol.2431062144 · Cited by 1,018
Parfrey, P. S., Griffiths, S. M., Barrett, B. J., Paul, M. D., Genge, M., Withers, J., Farid, N., & McManamon, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901193200303 · Cited by 1,011
ACR Guidance Document for Safe MR Practices: 2007
Kanal, E., Barkovich, A. J., Bell, C., Borgstede, J. P., Bradley, W. G., Froelich, J. W., Gilk, T., Gimbel, J. R., Gosbee, J., Kuhni-Kaminski, E., et al. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1616 · Cited by 787
Gadolinium-based MR Contrast Agents and Nephrogenic Systemic Fibrosis
Kuo, P. H., Kanal, E., Abu-Alfa, A. K., & Cowper, S. E. (2007) · Radiology · doi:10.1148/radiol.2423061640 · Cited by 630
Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned
Broome, D. R., Girguis, M. S., Baron, P. W., Cottrell, A. C., Kjellin, I., & Kirk, G. A. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1094 · Cited by 604
Evaluation of the Modification of Diet in Renal Disease Study Equation in a Large Diverse Population
Stevens, L. A., Coresh, J., Feldman, H. I., Greene, T., Lash, J. P., Nelson, R. G., Rahman, M., Deysher, A. E., Zhang, Y. (., Schmid, C. H., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020199 · Cited by 574
Trends in Adverse Events After IV Administration of Contrast Media
Cochran, S. T., Bomyea, K., & Sayre, J. W. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.176.6.1761385 · Cited by 358
Collidge, T. A., Thomson, P. C., Mark, P. B., Traynor, J. P., Jardine, A. G., Morris, S. T. W., Simpson, K., & Roditi, G. H. (2007) · Radiology · doi:10.1148/radiol.2451070353 · Cited by 319
Gadolinium and nephrogenic systemic fibrosis
Grobner, T., & Prischl, F. C. (2007) · Kidney International · doi:10.1038/sj.ki.5002338 · Cited by 293
Description of 12 Cases of Nephrogenic Fibrosing Dermopathy and Review of the Literature
Mendoza, F. A., Artlett, C. M., Sandorfi, N., Latinis, K., Piera-Velazquez, S., & Jimenez, S. A. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.08.002 · Cited by 262
Deo, A., Fogel, M., & Cowper, S. E. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03921106 · Cited by 259
Nephrogenic Fibrosing Dermopathy With Systemic Involvement
Ting, W. W., Stone, M. S., Madison, K. C., & Kurtz, K. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.7.903 · Cited by 258
Rydahl, C., Thomsen, H. S., & Marckmann, P. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e31815a3407 · Cited by 252
Poggio, E. D., Nef, P. C., Wang, X., Greene, T., Van Lente, F., Dennis, V. W., & Hall, P. M. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.04.023 · Cited by 218
Morcos, S. K. (2007) · The British Journal of Radiology · doi:10.1259/bjr/17111243 · Cited by 205
Case-control study of gadodiamide-related nephrogenic systemic fibrosis
Marckmann, P., Skov, L., Rossen, K., Heaf, J. G., & Thomsen, H. S. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm261 · Cited by 204
Shamam, Y. M., & Jesús, O. D. (2021) · StatPearls · Cited by 189
Thomsen, H. S., Morcos, S. K., & Dawson, P. (2006) · Clinical Radiology · doi:10.1016/j.crad.2006.09.003 · Cited by 153
Nephrogenic Systemic Fibrosis, Gadolinium, and Iron Mobilization
Swaminathan, S., Horn, T. D., Pellowski, D. M., Abul‐Ezz, S. R., Bornhorst, J. A., Viswamitra, S., & Shah, S. V. (2007) · New England Journal of Medicine · doi:10.1056/nejmc070248 · Cited by 123
Response to the FDA's May 23, 2007, Nephrogenic Systemic Fibrosis Update
Kanal, E., Broome, D. R., Martín, D. R., & Thomsen, H. S. (2007) · Radiology · doi:10.1148/radiol.2461071267 · Cited by 91
Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?
Bongartz, G. (2007) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-007-0071-5 · Cited by 51
Cited by
Gwenzi, W., Mangori, L., Danha, C., Chaukura, N., Dunjana, N., & Sanganyado, E. (2018) · Science of The Total Environment · doi:10.1016/j.scitotenv.2018.04.235 · Cited by 795
ACR Guidance Document for Safe MR Practices: 2007
Kanal, E., Barkovich, A. J., Bell, C., Borgstede, J. P., Bradley, W. G., Froelich, J. W., Gilk, T., Gimbel, J. R., Gosbee, J., Kuhni-Kaminski, E., et al. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1616 · Cited by 787
Davenport, M. S., Perazella, M. A., Yee, J., Dillman, J. R., Fine, D., McDonald, R. J., Rodby, R. A., Wang, C. L., & Weinreb, J. C. (2020) · Radiology · doi:10.1148/radiol.2019192094 · Cited by 601
Takeuchi, M., Sasaki, S., Ito, M., Okada, S., Takahashi, S., Kawai, T., Suzuki, K., Oshima, H., Hara, M., & Shibamoto, Y. (2009) · Radiology · doi:10.1148/radiol.2511080873 · Cited by 372
Kribben, A., Witzke, O., Hillen, U., Barkhausen, J., Daul, A. E., & Erbel, R. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.061 · Cited by 264
Metadata
- Authors
- Prince, M. R., Zhang, H., Morris, M., MacGregor, J. L., Grossman, M. E., Silberzweig, J., DeLapaz, R. L., Lee, H. J., Magro, C. M., & Valeri, A. M.
- Venue
- Radiology
- Published
- 2008-09
- Volume
- 248
- Issue
- 3
- Pages
- 807-816
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W1999260980
- Cited by
- 290
- References
- 24
- FWCI
- 21.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.